Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Cash from Investing Activities (2017 - 2023)

Historic Cash from Investing Activities for vTv Therapeutics (VTVT) over the last 6 years, with Q4 2023 value amounting to $4.4 million.

  • vTv Therapeutics' Cash from Investing Activities changed N/A to $4.4 million in Q4 2023 from the same period last year, while for Dec 2023 it was $4.4 million, marking a year-over-year change of. This contributed to the annual value of $4.4 million for FY2023, which is 2107142.86% up from last year.
  • Latest data reveals that vTv Therapeutics reported Cash from Investing Activities of $4.4 million as of Q4 2023.
  • vTv Therapeutics' Cash from Investing Activities' 5-year high stood at $4.4 million during Q4 2023, with a 5-year trough of -$68000.0 in Q4 2019.